Ramón Lecumberri Villamediana-rekin lankidetzan egindako argitalpenak (33)

2023

  1. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

    Journal of Clinical Medicine, Vol. 12, Núm. 4

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

  2. Impact of the mutation profile on thrombotic risk in cancer patients

    Revista Clinica Espanola, Vol. 222, Núm. 2, pp. 93-99

2021

  1. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

    Frontiers in Neurology, Vol. 12

2019

  1. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

  2. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

  3. New mechanisms in vein thrombosis: Immunothrombosis

    Medicina Clinica, Vol. 153, Núm. 2, pp. 78-81

2018

  1. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

    PLoS ONE, Vol. 13, Núm. 8

2016

  1. Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

    European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136

  2. La aplicación de un protocolo de gestión para la hemorragia masiva reduce la mortalidad en pacientes con hemorragia no traumática: Resultados de la auditoría de un centro

    Medicina Intensiva, Vol. 40, Núm. 9, pp. 550-559

2015

  1. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study

    Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148

  2. Short-term heparin re-exposure during heart transplantation in patients with ventricular assist devices and acute heparin-induced thrombocytopenia

    Revista Espanola de Cardiologia

2014

  1. Seguridad y eficacia de un concentrado de complejo protrombínico en pacientes con coagulopatía y hemorragia

    Anales del sistema sanitario de Navarra, Vol. 37, Núm. 3, pp. 363-369

2013

  1. High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

    Thrombosis and Haemostasis, Vol. 110, Núm. 1, pp. 184-190

  2. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism

    International Journal of Cancer, Vol. 133, Núm. 9, pp. 2157-2164

2012

  1. Trombofilia y trombosis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 22, pp. 1345-1352

2011

  1. Aplicabilidad clínica de la determinación de dímero-D en pacientes con cáncer

    Medicina Clinica, Vol. 137, Núm. 10, pp. 453-458

  2. Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients

    Journal of Thrombosis and Haemostasis, Vol. 9, Núm. 6, pp. 1108-1115

  3. Trombosis y fármacos antitrombóticos en el anciano

    Medicina Clinica, Vol. 137, Núm. 10, pp. 468-471

2009

  1. Coagulación 2009: una visión moderna de la hemostasia

    Revista de medicina, Vol. 53, Núm. 1, pp. 19-23